|
Pharmaceutical Products – Delivery Of Medicinal Products From The Group: Medicines Available Under The Drug Program; Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition; Anticancer And Immunomodulatory Drugs And Non-Specific Immunoglobulins (According To The Atc Classification) – From A List Of 31 Packages. Mitomycinum,Durvalumab,Daunorubicine,Glophitamabum,Thalidomidum,Tacrolimusum,Tacrolimusum,Regorafenibum,Trastuzumab Deruxtecan,Tebentafuspum,Sacituzumabum Govitecanum,Ramucirumabum,Polatuzumabum Vedotinum,Peginterferonum Alfa-2A,Nintedanibum,Mycophenolate Mofetil,Lorlatinibum,Immunoglobulins Intravenous, Solution 10%, Igg Content ≥ 98%, Iga Content ≤ 0.025 Mg/Ml,Immunoglobulins Intravenous, Solution 10%, Igg Content ≥ 98%, Iga Content ≤ 0.14 Mg/Ml,Denosumabum,Denosumabum,Landumumabum,Darolutamidum,Cytarabine,Cemiplimabum,Cabozantinibum,Azacitidine,Alpelisibum,Netupitanum + Palonosetroni Hydrochloricum,Propofolum,Belantamab Mafodotin
|
